Pfizer, Saama Partner on AI Clinical Trial Platform

Reporting on the Saama/Pfizer partnership, Outsourcing-Pharma explains how the two companies “will work together to develop and deploy an artificial intelligence (AI) powered analytical tool geared toward clearing many of the obstacles faced by study data managers and monitors.”

The partnership, born out of a competitive hackathon where Saama’s performance gained the attention of Pfizer executives, combines Saama’s Life Science Analytics Cloud (LSAC) platform with Pfizer’s clinical data and domain knowledge. Deep learning models will be created and trained to make predictive analytics with unprecedented accuracy.

Demetris Zambas, VP and head of data monitoring and management at Pfizer, says that “Through our strategic collaboration with Saama Technologies, we’ve identified efficiencies to improve processes and experiences for our clinical research partners.”